Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FBGFZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $125,244
Award facts
- Contract value 100% obligated
- $125,244.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Entresto 24 mg-26 mg tablets in a quantity of 180 tablets, with a ceiling value of $125,244.09. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a direct delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement as a critical vendor for military and veteran healthcare systems. The delivery order for Entresto, a cardiac medication, exemplifies the company's role in supplying brand-name pharmaceuticals across multiple therapeutic domains through the DLA Medical Supply Chain. As a child contract under the SPE2DX prime indefinite delivery vehicle, this delivery order supports the Defense Health Agency and related government healthcare systems without set-aside designation, demonstrating AmerisourceBergen's continued capability to meet federal procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FBGFZ?
SPE2DB25FBGFZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FBGFZ worth?
The government has obligated $125,244 on SPE2DB25FBGFZ.
Is contract SPE2DB25FBGFZ an order under another contract?
Yes. SPE2DB25FBGFZ is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGFZ competed?
The extent of competition for SPE2DB25FBGFZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award